Trial intelligence / Profile preview

Tenofovir in HIV/HBV Co-infection

NCT00192595Phase 4Completed

Sponsor
The Kirby Institute
Start
Jan 2004
Primary completion
Jan 2007
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of tenofovir in hepatitis B (HBV), sponsored by The Kirby Institute. Started Jan 2004; status: completed.

02

Drugs

tenofovir
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00192595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00192595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call